Evidence map›Paper›PMID 30060630›Full record

ArticleInternational journal of molecular sciences2018

Novel Neohesperidin Dihydrochalcone Analogue Inhibits Adipogenic Differentiation of Human Adipose-Derived Stem Cells through the Nrf2 Pathway.

Ga Eun Han, Hee-Taik Kang, Sungkyun Chung, Changjin Lim, John A Linton, Jin-Hee Lee, Wooki Kim, Seok-Ho Kim, Jong Hun Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Re-evaluation of neohesperidine dihydrochalcone (E 959) as a food additive.EFSA journal. European Food Safety Authority · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Potential Applications of NRF2 Inhibitors in Cancer Therapy.Oxidative medicine and cellular longevity · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Ga Eun HanDepartment of Food science and Biotechnology, College of Life Science, CHA University, Seongnam-si 13488, Korea. hke112@naver.com.
Hee-Taik KangDepartment of Family Medicine, College of Medicine, Chungbuk National University, Chungbuk 28644, Korea. kanght0818@gmail.com.ORCID 0000-0001-8048-6247
Sungkyun ChungDepartment of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Seongnam-si 13488, Korea. wjdtjdrbs123@naver.com.
Changjin LimDepartment of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Seongnam-si 13488, Korea. koryoi0709@gmail.com.
John A LintonDepartment of Family Medicine, Severance Hospital, Yonsei University, Seoul 03722, Korea. yohan@yuhs.ac.
Jin-Hee LeeDepartment of Food science and Biotechnology, College of Life Science, CHA University, Seongnam-si 13488, Korea. jhlee81@cha.ac.kr.
Wooki KimDepartment of Food Science and Biotechnology, Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Korea. kimw@khu.ac.kr.
Seok-Ho KimDepartment of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Seongnam-si 13488, Korea. ksh3410@cha.co.kr.
Jong Hun LeeDepartment of Food science and Biotechnology, College of Life Science, CHA University, Seongnam-si 13488, Korea. foodguy@cha.ac.kr.
CHA University · KRChungbuk National University · KRKyung Hee University · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity, characterized by excess lipid accumulation, has emerged as a leading public health problem. Excessive, adipocyte-induced lipid accumulation raises the risk of metabolic disorders. Adipose-derived stem cells (ASCs) are mesenchymal stem cells (MSCs) that can be obtained from abundant adipose tissue. High fat mass could be caused by an increase in the size (hypertrophy) and number (hyperplasia) of adipocytes. Reactive oxygen species (ROS) are involved in the adipogenic differentiation of human adipose-derived stem cells (hASCs). Lowering the level of ROS is important to blocking or retarding the adipogenic differentiation of hASCs. Nuclear factor erythroid 2-related factor-2 (Nrf2) is a transcription factor that mediates various antioxidant enzymes and regulates cellular ROS levels. Neohesperidin dihydrochalcone (NHDC), widely used as artificial sweetener, has been shown to have significant free radical scavenging activity. In the present study, (

Indexed as

AdipogenesisAdipose TissueCell LineCells, CulturedChalconesHesperidinHumansNF-E2-Related Factor 2Reactive Oxygen SpeciesSignal TransductionStem CellsChalconesHesperidinneohesperidin dihydrochalconeNFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen Speciesadipogenic differentiationadipose stem cellsneohesperidin dihydrochalconeNrf2reactive oxygen species

Identifiers

PMID30060630
PMCPMC6121477
OpenAlexW2884631477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.